Biopharmazeutische CMO- und CRO-Marktgröße, Anteilsanalyse bis 2025-2031
Biopharmaceutical CMO and CRO Market Report Analysis
Biopharmaceutical CMO and CRO Market
-
CAGR (2025 - 2031)5.8% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- AGC Biologics
- Boehringer Ingelheim International GmbH
- FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- TOYOBO CO., LTD
- JRS PHARMA
- Lonza
- PRA Health Sciences, Inc.
- ProBioGen AG
- Rentschler Biopharma SE
Regional Overview

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation

- Säugetier
- Nicht-Säugetier

- Auftragsfertigung
- Auftragsforschung

- Biologika
- Biosimilars
- Impfstoffe

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika